Consolidation therapy with blinatumomab improves overall survival in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in measurable residual disease negative remission: Results from the ECOG-ACRIN E1910 Randomized phase III National Cooperative Clinical Trials Network trial Meeting Abstract
| Authors: | Litzow, M. R.; Sun, Z.; Paietta, E.; Mattison, R. J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; Mullighan, C. G.; Willman, C. L.; Zhang, Y.; Wieduwilt, M.; Liedtke, M.; Bergeron, J.; Pratz, K. W.; Dinner, S.; Frey, N. V.; Gore, S. D.; Bhatnagar, B.; Atallah, E. L.; Uy, G. L.; Jeyakumar, D.; Lin, T. L.; Little, R. F.; Luger, S. M.; Tallman, M. S. |
| Abstract Title: | Consolidation therapy with blinatumomab improves overall survival in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in measurable residual disease negative remission: Results from the ECOG-ACRIN E1910 Randomized phase III National Cooperative Clinical Trials Network trial |
| Meeting Title: | 64rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-12-06 |
| Language: | English |
| ACCESSION: | WOS:000897957100002 |
| DOI: | 10.1182/blood-2022-171751 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA-1 -- Source: Wos |
